Serban Ghiorghiu | Chief Safety Officer
AstraZeneca

Serban Ghiorghiu Chief Safety Officer, AstraZeneca  Serban is AstraZeneca Chief Safety Officer and leads the organization that delivers patient safety leadership across all AstraZeneca’ therapy areas (Oncology, CVRM, R&I, V&I, and Rare Diseases) to bring life changing medicines to patients. He also leads the Global Patient Science organization responsible for the delivery of best practices in patient centred clinical trials, patient experience and outcomes. Serban is passionate about reimagining Patient Safety to redefine care and outcomes through collaboration, innovation and pursuit of science. His main research interests include clinical excellence in drug development, accelerating innovation and improving health equity at the intersection between society, industry, academia and government.  From 2019-2021, Serban Ghiorghiu was a member of the European Commission’s Mission Board for Cancer designed to focus on reducing cancer burden.   Serban graduated from University of Medicine and Pharmacy “Gr. T. Popa” Iasi, Romania and trained as a medical oncologist, also in Iasi. His work is supported by papers in influential peer-reviewed publications, including New England Journal of Medicine, Lancet Oncology, Jama Oncology and the Journal of Clinical Oncology.